Chronic disease is increasingly reshaping Canada’s health-care landscape and driving continued growth in prescription drug spending, according to a new report by GreenShield.

The report, based on nearly 39 million drug claims adjudicated in 2025, found plan sponsors’ drug costs rose 9.5 per cent in 2025, reaching $3 billion, reflecting growing demand for treatments related to diabetes, obesity and other chronic conditions. Costs related to diabetes and weight management treatments increased 47.7 per cent year over year, highlighting the growing impact of chronic disease on benefit plans.

Read: Drug savings programs can alleviate cost pressures for private plans, impact plan design: expert

The number of........

© Benefits Canada